First Week of February 2026 Options Trading For Gilead Sciences(GILD)

Analysis of Gilead Sciences (GILD) options reveals potential strategies for investors seeking enhanced yield. Selling the $105 put offers a 64% probability of expiring worthless, yielding a 6.71% return on cash commitment, while a covered call strategy at the $115 strike has a 51% chance of expiring worthless, boosting returns by 7.23%; Stock Options Channel will track these probabilities.

Analysis

The article details two specific options strategies for Gilead Sciences (GILD), which is currently trading at $107.87 per share. Firstly, selling a cash-secured put contract at the $105.00 strike price, which is approximately 3% out-of-the-money, yields a premium of $7.05. This strategy implies a commitment to purchase GILD shares at an effective cost basis of $97.95 if the option is exercised. Analytical data indicates a 64% probability of this put option expiring worthless, which would result in a 6.71% return on the cash commitment, equivalent to a 10.00% annualized yield. Secondly, for investors already holding GILD shares, a covered call strategy involves selling the $115.00 strike call option, approximately 7% out-of-the-money, for a premium of $7.80. If GILD's stock price is above $115.00 at the February 2026 expiration and the shares are called away, this would yield a total return of 13.84% (excluding dividends, before commissions). There is a 51% assessed probability of this call option expiring worthless, in which case the collected premium would represent a 7.23% boost to returns, or 10.77% annualized. The implied volatility for the put option is 31%, and for the call option, it is 29%. Both figures are higher than GILD's actual trailing twelve-month volatility of 26%, suggesting that option premiums might be relatively attractive for sellers. These strategies offer investors potential avenues for acquiring shares at a reduced cost basis or for enhancing yield on existing GILD holdings, contingent on the stock's price movements.

Key Decisions for Investors

• Investors considering initiating or adding to a GILD position could evaluate selling the $105 strike puts to potentially acquire shares at an effective cost basis of $97.95, a discount to the current $107.87 price, or to generate a 10.00% annualized yield if the option expires worthless, given its 64% assessed probability.
• For portfolios currently holding Gilead Sciences, writing the $115 strike covered calls for the February 2026 expiration could be a strategy to achieve a potential 10.77% annualized yield enhancement if the shares are not called away, or a 13.84% total return if called, noting the 51% probability of the option expiring worthless.
• Given that GILD's option implied volatilities (29-31%) are moderately above its 26% trailing twelve-month historical volatility, net premium selling strategies might be advantageous; however, comprehensive due diligence on Gilead Sciences' business fundamentals remains crucial before implementing such options strategies.